High throughput multiplexed characterization and modeling of antibody antigen binding with application to HSV

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 1R43AI132075-01
Agency Tracking Number: R43AI132075
Amount: $299,999.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: NIAID
Solicitation Number: PA16-302
Timeline
Solicitation Year: 2016
Award Year: 2017
Award Start Date (Proposal Award Date): 2017-02-01
Award End Date (Contract End Date): 2019-01-31
Small Business Information
825 N 300 W STE C325, Salt Lake City, UT, 84103-1459
DUNS: 171205177
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 BENJAMIN BROOKSPHD
 (801) 885-4073
 bbrooks@microfl.com
Business Contact
 JOSH ECKMAN
Phone: (801) 532-4486
Email: jeckman@microfl.com
Research Institution
N/A
Abstract
Abstract All therapeutic antibodies and most vaccines critically depend on the ability of antibodies to specifically recognize particular antigens consequently detailed characterization of antibody antigen binding can provide invaluable information to understand and guide development Unfortunately due to the time and expense required atomic resolution structure determination is typically used sparingly late in a development process or for a small number of different antibodies or antigen variants We seek to enable earlier and larger scale but still detailed characterization and modeling of antibody antigen binding applicable to panels of antibodies that could result from screening polyclonal samples or engineered libraries along with panels of antigens that could result from attempts to understand and account for diversity across populations While not at atomic resolution our approach will still allow residue level localization of specific epitopes for specific antibodies as well as group level identification of functionally similar antibodies and their associated binding regions on the antigen The approach will be enabled by a unique integration of a powerful experimental platform the high throughput multiplexed Wasatch Surface Plasmon Resonance SPR with powerful computational methods to design and analyze binding experiments Studies of glycoprotein D gD of herpes simplex virus HSV will provide a solid foundation for developing testing and applying the technology to better understand critical differences across antibodies and antigenic variation Ultimately the approaches developed here will allow researchers to leverage extensive epitope characterization data generated with Wasatchandapos s SPR instrument in order to broadly and deeply characterize the basis for antibody antigen recognition in wide ranging vaccine and therapeutic antibody discovery and development programs Project Narrative Detailed characterization of antibody antigen binding is fundamental to understanding and potentially improving mechanisms of action of biotherapeutics and vaccines Here in order to support such characterization for large panels of related antibodies and antigen variants computational design and analysis methods will be integrated with a high throughput multiplexed experimental platform enabling the overall grouping of antibodies by binding preferences as well as the detailed localization of particular antibody epitopes By enabling a rich analysis at much higher throughput than traditional structural studies this approach promises to better drive discovery and development of vaccines and therapeutic antibodies

* Information listed above is at the time of submission. *

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government